These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 4237065)

  • 1. Studies on the prekallikrein (kallikreinogen)--kallikrein enzyme system of human plasma. II. Evidence relating the kaolin-activated arginine esterase to plasma kallikrein.
    Colman RW; Mattler L; Sherry S
    J Clin Invest; 1969 Jan; 48(1):23-32. PubMed ID: 4237065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human plasma alpha 2-macroglobulin. An inhibitor of plasma kallikrein.
    Harpel PC
    J Exp Med; 1970 Aug; 132(2):329-52. PubMed ID: 4101346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Observations on the plasma kallikreinogen (prekallikrein)-kallikrein enzyme system.
    Sherry S; Colman RW
    Trans Assoc Am Physicians; 1968; 81():40-8. PubMed ID: 5305252
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on the prekallikrein (kallikreinogen)--kallikrein enzyme system of human plasma. I. Isolation and purification of plasma kallikreins.
    Colman RW; Mattler L; Sherry S
    J Clin Invest; 1969 Jan; 48(1):11-22. PubMed ID: 4974623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contact activation of human plasma prorenin in vitro.
    Blumberg AL; Sealey JE; Atlas SA; Laragh JH; Dharmgrongartama B; Kaplan AP
    J Lab Clin Med; 1981 Jun; 97(6):771-8. PubMed ID: 7014741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prekallikrein activator and kallikrein in acetone- and kaolin-activated rat plasma.
    Berstad J
    Acta Pharmacol Toxicol (Copenh); 1979 Sep; 45(3):174-80. PubMed ID: 506739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunochemical studies of plasma kallikrein.
    Bagdasarian A; Lahiri B; Talamo RC; Wong P; Colman RW
    J Clin Invest; 1974 Dec; 54(6):1444-54. PubMed ID: 4140197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The kallikreinogen-kallikrein enzyme system of human plasma. Assay of components and observations in disease states.
    Colman RW; Mason JW; Sherry S
    Ann Intern Med; 1969 Oct; 71(4):763-73. PubMed ID: 5360288
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma arginine esterase in cystic fibrosis: kinetics of activation, identification as plasma kallikrein, reaction with alpha 2-macroglobulin and comparison with levels in normal plasma.
    Bury AF; Barrett AJ
    Pediatr Res; 1982 Aug; 16(8):613-20. PubMed ID: 6180371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arginine esterase in cerebrospinal fluid and pro-arginine esterase in plasma from patients with migraine.
    Briseid K; Falkum A; Qvigstad EK; Stien R
    Acta Neurol Scand; 1976 Oct; 54(4):301-11. PubMed ID: 973552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normal plasma arginine esterase and the Hageman factor (factor XII) -prekallikrein-kininogen system in cystic fibrosis.
    Goldsmith GH; Stern RC; Saito H; Ratnoff OD
    J Lab Clin Med; 1977 Jan; 89(1):131-4. PubMed ID: 830773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration of factor VII activity by activated Fletcher factor (a plasma kallikrein): a potential link between the intrinsic and extrinsic blood-clotting systems.
    Saito H; Ratnoff OD
    J Lab Clin Med; 1975 Mar; 85(3):405-15. PubMed ID: 234996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor.
    Scott CF; Silver LD; Schapira M; Colman RW
    J Clin Invest; 1984 Apr; 73(4):954-62. PubMed ID: 6561202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prekallikein and kallikrein inhibitor in liver cirrhosis and hepatitis.
    Faciullacci M; Galli P; Monetti MG; Pela I; Del Bianco PL
    Adv Exp Med Biol; 1976; 70(00):201-8. PubMed ID: 1084679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of precipitating antibodies to pancreatic kallikrein on arginine esterase contact activation in human and rabbit blood].
    Karpitskiĭ VV; Guz SIa
    Vopr Med Khim; 1979; 25(3):242-5. PubMed ID: 452486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of the plasma kinin-generating system in children with the minimal lesion, idiopathic nephrotic syndrome.
    Kallen RJ; Lee SK
    Pediatr Res; 1975 Sep; 9(9):705-9. PubMed ID: 53808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of surface-mediated activation of bovine Factor XII and prekallikrein.
    Sugo T; Ohno Y; Shimada T; Kato H; Iwanaga S
    Adv Exp Med Biol; 1983; 156():87-107. PubMed ID: 6602465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of arginine and tyrosine esterase in serum from patients with hereditary angio-oedema.
    Eisen V; Loveday C
    Br J Pharmacol; 1972 Sep; 46(1):157-66. PubMed ID: 5084818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma kallikrein-mediated activation of the renin-angiotensin system does not require prior acidification of prorenin.
    Derkx FH; Schalekamp MP; Bouma B; Kluft C; Schalekamp MA
    J Clin Endocrinol Metab; 1982 Feb; 54(2):343-8. PubMed ID: 6459340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nature of the proteinase activated by the contact factor in human blood plasma].
    Veremeenko KN; Kizim AI; Lositskaia VM
    Vopr Med Khim; 1977; (3):391-6. PubMed ID: 196405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.